SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-11-094151
Filing Date
2011-04-12
Accepted
2011-04-11 21:36:19
Documents
4
Period of Report
2011-01-14
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM 8-K d8ka.htm 8-K/A 18358
2 CONSENT OF GRANT THORNTON LLP dex231.htm EX-23.1 1896
3 AUDITED FINANCIAL STATEMENTS OF CYDEX PHARMACEUTICAL, INC. dex991.htm EX-99.1 359756
4 PRO FORMA FINANCIAL INFORMATION dex992.htm EX-99.2 205395
  Complete submission text file 0001193125-11-094151.txt   586571
Mailing Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037
Business Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33093 | Film No.: 11753704
SIC: 2834 Pharmaceutical Preparations